Neuland Laboratories Limited (NSE:NEULANDLAB)
India
· Delayed Price · Currency is INR 13,030
+1,286 (10.95%)
Jun 6, 2025, 3:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Active Pharmaceutical Ingredients and Allied Services | 15.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Active Pharmaceutical Ingredients and Allied Services Growth | 30.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Export Incentives | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Export Incentives Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scrap | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Scrap Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Impurities | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Impurities Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| North America | 8.42B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 38.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 5.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 38.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 623.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 74.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Latin America | 467.57M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Latin America Growth | -1.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC | 311.72M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC Growth | -47.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Middle East and North Africa | 155.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Middle East and North Africa Growth | -56.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India | 155.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 30.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|